2. Baseline information.
| Study | Group | Sample size (n) | Participants (n (%)) | Dropouts (n (%)) | % Male | Mean age (years) | % HTN | % DM | % HLD | % Prior MI | % Anterior STEMI |
| CvLPRIT 2015 | Complete | 150 | 139 (92.7) | 11 (7.3) | 85.3 | 64.6 | 36 | 12.7 | 27.3 | 4.7 | 36 |
| Culprit‐only | 146 | 139 (95.2) | 8 (5.5) | 76.7 | 65.3 | 35 | 13.7 | 23.3 | 3.4 | 35.6 | |
| Dambrink and Ghani 2010 | Complete | 80 | 71 (88.8) | 1 (1.3) | 80 | 62 | 26.3 | 6.3 | 15 | 6.3 | 21.3 |
| Culprit‐only | 41 | 41 (100) | 1 (2.4) | 80.5 | 61 | 42.5 | 5 | 30 | 4.9 | 23.3 | |
| DANAMI‐3‐PRIMULTI 2015 | Complete | 314 | 294 (93.6) | 1 (0.3) | 80 | 64 | 41.4 | 9.2 | NR | 5.4 | 33.4 |
| Culprit‐only | 313 | 313 (100) | 0 | 81.5 | 63 | 46.6 | 13.4 | NR | 8.6 | 35.8 | |
| Estevez Loureiro 2014 | Complete | 100 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Culprit‐only | 99 | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
| HELP AMI 2004 | Complete | 52 | NR | NR | 88.5 | 63.5 | 36.5 | 11.5 | 41.2 | NR | 52 |
| Culprit‐only | 17 | NR | NR | 82.4 | 65.3 | 58.8 | 41.2 | 53 | NR | 59 | |
| Politi 2009 | Complete | 130 | NR | NR | 78.5 | 64 | 57 | 16.2 | NR | NR | 45.4 |
| Culprit‐only | 84 | NR | NR | 76.2 | 66.5 | 60 | 23.8 | NR | NR | 41.7 | |
| PRAGUE‐13 2015 | Complete | 106 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Culprit‐only | 108 | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
| PRAMI 2013 | Complete | 234 | 223 (95.3) | 10 (4.3) | 75.6 | 62 | 40.2 | 15 | NR | 8.1 | 28.6 |
| Culprit‐only | 231 | 229 (99) | 8 (3.5) | 80.5 | 62 | 40.3 | 20.8 | NR | 7 | 38.5 | |
| Zhang 2015 | Complete | 215 | NR | NR | 61 | 62.3 | 64.2 | 36.7 | 35.3 | NR | 36.7 |
| Culprit‐only | 213 | NR | NR | 67.1 | 62 | 61 | 35.2 | 36.6 | NR | 40 |
DM: diabetes mellitus; HLD: hyperlipidaemia; HTN: hypertension; MI: myocardial infarction; n: number of participants; NR: not reported in the article; STEMI: ST elevated myocardial infarction.